On Thursday, Steris received a positive adjustment to its Relative Strength (RS) Rating, from 77 to 84.
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.
Decades of market research reveals that the best stocks often have an RS Rating of over 80 in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Steris is building a with a 248.24 buy point. See if it can clear the breakout price in volume at least 40% above average.
Steris showed 11% earnings growth last quarter, while sales growth came in at 6%.
The company earns the No. 5 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
